South & Central America GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
The South & Central America GMP cell therapy consumables market is expected to grow from US$ 584.43 million in 2022 to US$ 2,579.39 million by 2028; it is estimated to grow at a CAGR of 28.0% from 2022 to 2028.
Increasing Clinical Trials and Rising GMP Demand is Fueling the South & Central America GMP Cell Therapy Consumables Market
Cell therapies are constantly evolving, improving, and providing new treatment options for various disorders, such as cancer, autoimmune disorders, and neurological disorders. Immunotherapy is a new approach for cancer treatment. Cell therapies are currently being evaluated in clinical trials for various cancer types, separately and combined with other treatments. Additionally, the cellular immunotherapy targets that are being evaluated in clinical trials, new immunotherapy approaches are also being developed constantly, which is investigated through clinical trials. Since 2017, FDA approved about six chimeric antigen receptor (CAR) T-cell therapies for the treatment of blood cancer, including lymphomas, some leukemia forms, and multiple myeloma. More than 500 CAR-T and 17 chimeric antigen receptor natural killer (CAR-NK) cell trials are currently being conducted across the world, including the four CAR-T cell products—Yescarta, Tecartus, Kymriah, and Breyanzi that are already available in the market. Further, the CAR cellular therapies field is newly developed, and preclinical and clinical studies have already shown remarkable results. It is believed that CAR-based cellular therapies are profoundly promising and will lead the development of approved personalized therapeutic options in the coming years. With new therapeutic modalities emerging in the cell and gene space (CAR-T), companies are required to develop, evaluate, and test these therapies in clinical trials, along with maintaining patient safety. These emerging therapies require a scientific standard of controls and GMPs to ensure patient safety. Thus, it is important to ensure that the equipment used during these processes is compatible with GMP manufacturing environments for cell therapies, and all clinical consumables are manufactured under conditions that fulfil GMP requirements appropriate for the phase and scale of manufacturing. Therefore, the increasing clinical trials among various fields will fuel the South & Central America GMP cell therapy consumables market.
South & Central America GMP Cell Therapy Consumables Market Overview
The South & Central America GMP cell therapy consumables market includes Brazil, Argentina, and the Rest of South & Central America. The region held the smallest portion of the market in the global analysis. The market for cell therapy consumables in the region is expected to have growth opportunities during the forecast period. The GMP cell therapy consumables market in the SAM region is expected to grow owing to factors such as, establishment of pharmaceutical companies in the region, increasing awareness, and rising healthcare expenditure by the countries, the high adoption rate of cell therapy and increased in medical tourism are likely to create demand for GMP cell therapy consumables during the forecast period. Furthermore, increase in research activities and increased use of advanced medicinal products are likely to amplify the market growth.
South & Central America GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)
South & Central America GMP Cell Therapy Consumables Market Segmentation
The South & Central America GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.
Based on product, the South & Central America GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the market in 2022.
Based on cell therapy, the South & Central America GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the market in 2022.
Based on process, the South & Central America GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the market in 2022.
Based on end use, the South & Central America GMP cell therapy consumables market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the market in 2022.
Based on country, the South & Central America GMP cell therapy consumables market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the market in 2022.
Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the South & Central America GMP cell therapy consumables market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America GMP Cell Therapy Consumables Market – by Product
1.3.2 South & Central America GMP Cell Therapy Consumables Market – by Cell Therapy
1.3.3 South & Central America GMP Cell Therapy Consumables Market – by End Use
1.3.4 South & Central America GMP Cell Therapy Consumables Market – by End Use
1.3.5 South & Central America GMP Cell Therapy Consumables Market – by Country
2. South & Central America GMP Cell Therapy Consumables Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America GMP Cell Therapy Consumables Market – Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Experts’ Opinion
5. South & Central America GMP Cell Therapy Consumables Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Research & Development and Drug Discovery
5.1.2 Increase in Strategic Collaborations
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
5.3.1 Growing Regulatory Approvals for Cell and Gene Therapy (CGT) Product
5.4 Future Trends
5.4.1 Increasing Clinical Trials and Rising GMP Demand
5.5 Impact Analysis
6. GMP Cell Therapy Consumables Market – South & Central America Analysis
6.1 South & Central America GMP Cell Therapy Consumables Market Revenue Forecast and Analysis
7. South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Product
7.1 Overview
7.2 South & Central America GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Kits
7.3.1 Overview
7.3.2 Kits: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Reagents/ Molecular Biology Reagents
7.4.1 Overview
7.4.2 Reagents/ Molecular Biology Reagents: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers)
7.5.1 Overview
7.5.2 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
8. South & Central America GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 – by Cell Therapy
8.1 Overview
8.2 South & Central America GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
8.3 NK Cell Therapy
8.3.1 Overview
8.3.2 NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Stem Cell Therapy
8.4.1 Overview
8.4.2 Stem Cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
8.5 T-cell Therapy
8.5.1 Overview
8.5.2 T-cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9. South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by End Use
9.1 Overview
9.2 South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Clinical
9.3.1 Overview
9.3.2 Clinical: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Commercial
9.4.1 Overview
9.4.2 Commercial: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Research
9.5.1 Overview
9.5.2 Research: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10. South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Process
10.1 Overview
10.2 South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Cell Collection and Characterization/Sorting and Separation
10.3.1 Overview
10.3.2 Cell Collection and Characterization/ Sorting and Separation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Cell Culture and Expansion/Preparation
10.4.1 Overview
10.4.2 Cell Culture and Expansion/Preparation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Cryopreservation
10.5.1 Overview
10.5.2 Cryopreservation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Cell Processing and Formulation
10.6.1 Overview
10.6.2 Cell Processing and Formulation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Cell Isolation and Activation
10.7.1 Overview
10.7.2 Cell Isolation and Activation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Cell Distribution/Handling
10.8.1 Overview
10.8.2 Cell Distribution/Handling: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Process Monitoring and Control/Readministration/Quality Assurance
10.9.1 Overview
10.9.2 Process Monitoring and Control/Readministration/Quality Assurance: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
10.10 Other
10.10.1 Overview
10.10.2 Other: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
11. South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – Country Analysis
11.1 Overview
11.1.1 South & Central America: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
11.1.1.1 Brazil: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.1.1 Overview
11.1.1.1.2 Brazil: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.1.3 Brazil: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)
11.1.1.1.4 Brazil: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)
11.1.1.1.5 Brazil: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)
11.1.1.1.6 Brazil: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)
11.1.1.2 Argentina: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.2.1 Overview
11.1.1.2.2 Argentina: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.2.3 Argentina: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)
11.1.1.2.4 Argentina: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)
11.1.1.2.5 Argentina: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)
11.1.1.2.6 Argentina: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)
11.1.1.3 Rest of South & Central America: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.3.1 Overview
11.1.1.3.2 Rest of South & Central America: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.3.3 Rest of South & Central America: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)
11.1.1.3.4 Rest of South & Central America: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)
11.1.1.3.5 Rest of South & Central America: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)
11.1.1.3.6 Rest of South & Central America: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)
12. GMP Cell Therapy Consumables Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in GMP Cell Therapy Consumables Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Sartorius AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Miltenyi Biotec BV & Co KG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bio-Techne Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Corning Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 FUJIFILM Irvine Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Lonza Group AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BPS Bioscience Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Merck KGaA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Global Life Sciences Solutions USA LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. Brazil: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. Brazil: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. Brazil: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. Argentina: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. Argentina: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Argentina: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Argentina: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Rest of South & Central America: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Rest of South & Central America: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Rest of South & Central America: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Rest of South & Central America: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market
Table 14. Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America GMP Cell Therapy Consumables Market Segmentation
Figure 2. South & Central America GMP Cell Therapy Consumables Market, by Country
Figure 3. South & Central America GMP Cell Therapy Consumables Market Overview
Figure 4. Kits Segment Held the Largest Share of Product Segment in South & Central America GMP Cell Therapy Consumables Market
Figure 5. Argentina is Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. South & Central America GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America GMP Cell Therapy Consumables Market – Revenue Forecast and Analysis – 2019–2028
Figure 10. South & Central America GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
Figure 11. Kits: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Reagents/ Molecular Biology Reagents: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. South & Central America GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
Figure 16. NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Stem Cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. T-cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Applications: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
Figure 21. Clinical: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Commercial: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Research: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
Figure 25. Cell Collection and Characterization/Sorting and Separation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cell Culture and Expansion/Preparation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Cryopreservation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Cell Processing and Formulation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cell Isolation and Activation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Cell Distribution/Handling: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Process Monitoring and Control/Readministration/Quality Assurance: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Other: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. South & Central America: GMP Cell Therapy Consumables Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 34. South & Central America: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
Figure 35. Brazil: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 36. Argentina: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 37. Rest of South & Central America: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 38. Growth Strategies in GMP Cell Therapy Consumables Market
- Bio-Techne Corp
- BPS Bioscience Inc
- Corning Inc
- FUJIFILM Irvine Scientific Inc
- Global Life Sciences Solutions USA LLC
- Lonza Group AG
- Merck KGaA
- Miltenyi Biotec BV & Co KG
- Sartorius AG
- Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America GMP cell therapy consumables market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution